BioSpace News Archive

Roivant Sciences announced that it will host a live investor call and webcast at 8:00 AM ET on Wednesday, March 15 to review topline results from the ADORING 2 study, one of two replicate Phase 3 studies in atopic dermatitis.

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced financial results for the fourth quarter and year-ended December 31, 2022.

GeneDx Holdings Corp., a leader in delivering improved health outcomes through genomic and clinical insights, reported its financial results for the fourth quarter and full year ended December 31, 2022.

Vincerx Pharma, Inc. (Nasdaq: VINC) today announced four poster presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, being held virtually and at the Orange County Convention Center in Orlando, Florida from April 14-19, 2023.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that two abstracts have been accepted for poster presentations at the 2023 American Association for Cancer Research Annual Meeting taking place April 14-19, 2023, in Orlando, FL.

Sensei Biotherapeutics, Inc. will present new preclinical data on SNS-103, a conditionally active, monoclonal antibody targeting ENTPDase1 at the American Association for Cancer Research Annual Meeting 2023, being held April 14-19, 2023 in Orlando, FL.

Travere Therapeutics, Inc. announced that the Company will present a quantitative systems pharmacology model for predicting the effects of the investigational enzyme replacement therapy pegtibatinase, in classical homocystinuria, as well as real-world evidence on the prevalence and potential underdiagnosis and/or underreporting of HCU in the United States, at the 2023 Society for Inherited Metabolic Disorders 44th Annual Meeting in Salt Lake City, UT, March 18-21, 2023.

Immuneering Corporation (Nasdaq: IMRX) announced today that it will be presenting data on its lead program IMM-1-104 at the American Association for Cancer Research (AACR) annual meeting, held April 14-19 in Orlando, Florida.

Notable Labs, Inc. (“Notable”) today announced that results from a clinical validation study of its Predictive Precision Medicine Platform (PPMP) will be presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting being held in Orlando, Florida on April 14-19, 2023.

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced that it is participating in the 2023 American Academy of Dermatology Annual Meeting, which will take place on March 17-21 in New Orleans.